0001593968-23-000097.txt : 20230109 0001593968-23-000097.hdr.sgml : 20230109 20230109162420 ACCESSION NUMBER: 0001593968-23-000097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER ANDREW B CENTRAL INDEX KEY: 0001285221 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 23518404 BUSINESS ADDRESS: STREET 1: 440 CLYDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509305282 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2023-01-05 0000738214 AEMETIS, INC AMTX 0001285221 FOSTER ANDREW B 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President Option (right to buy) 3.75 2023-01-05 4 A false 12500 3.75 A 2023-04-05 2033-01-05 Common stock and Series B Preferred 12500 12500 D Option (right to buy) 3.75 2023-01-05 4 A false 137500 3.75 A 2023-04-05 2033-01-05 Common stock and Series B Preferred 137500 137500 D 1/12th of the Option Shares vest every three(3)months from the date of the grant. Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment. /s/Todd Waltz attorney-infact 2023-01-09